Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial.
J Immunother Cancer
; 9(11)2021 11.
Article
in En
| MEDLINE
| ID: mdl-34772758
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angiopoietin-2
/
CTLA-4 Antigen
/
Melanoma
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Immunother Cancer
Year:
2021
Document type:
Article
Affiliation country:
United States